Cardanol monoene, also known as anacardic acid (C15:1), is a phenolic compound found in cashew nut shell liquid (CNSL) [, ]. CNSL is a byproduct of cashew nut processing and has gained interest due to the presence of various bioactive compounds, including cardanol monoene []. This compound has emerged in scientific research due to its potential biological activities, which include inducing cell death in cancer cells and inhibiting enzymes involved in melanin production [, ].
Cardanol monoene has the chemical formula C21H34O and a molecular weight of 322.5 g/mol []. Its structure consists of a phenolic ring (benzene ring with a hydroxyl group) attached to a long, unsaturated alkyl chain (C15:1 indicates one double bond within the 15-carbon chain). The presence of the phenolic ring and the unsaturated alkyl chain contributes to the amphiphilic nature of the molecule, meaning it has both hydrophobic (water-fearing) and hydrophilic (water-loving) regions [].
Specific information on the synthesis of cardanol monoene is limited. However, research suggests CNSL undergoes a high-temperature decarboxylation process to yield cardanol (a saturated version of cardanol monoene) and other phenolic compounds [].
Cardanol monoene exhibits various chemical reactions due to its functional groups. Here are some examples:
Cardanol monoene can reversibly inhibit tyrosinase, an enzyme responsible for melanin production. This reaction has potential applications in skin lightening cosmetics []. The mechanism involves the phenolic group interacting with the active site of the enzyme, hindering substrate binding [].
Studies have shown cardanol monoene can induce apoptosis (programmed cell death) in human melanoma cells []. The exact mechanism is still under investigation, but it likely involves the interaction of the compound with the mitochondrial membrane, leading to the release of pro-apoptotic factors [].
As mentioned earlier, cardanol monoene exhibits two main mechanisms of action in scientific research:
Cardanol monoene exhibits promising potential in cancer research, particularly against melanoma. Studies have shown it to possess antioxidant properties [], potentially offering protection against cell damage linked to cancer development. Additionally, research suggests cardanol monoene can inhibit the growth of melanoma cells (M14 cell line) by halting the cell cycle and inducing apoptosis (programmed cell death) []. This effect is believed to be mediated through the generation of reactive oxygen species (ROS), leading to the intrinsic apoptotic pathway [].
Cardanol monoene demonstrates anti-tyrosinase activity, making it a potential candidate for skin lightening applications []. Tyrosinase is a key enzyme involved in melanin production, and its inhibition can help reduce skin pigmentation. Studies have shown cardanol monoene to reversibly inhibit tyrosinase with an IC50 value of 56 µM in vitro []. However, further research is needed to determine its effectiveness and safety for topical use in humans.
Cardanol monoene, along with other cardanol derivatives, has been investigated for its antimicrobial properties. When combined with metal ions, cardanol monoene can form complexes that inhibit biofilm formation by uropathogenic E. coli bacteria []. Biofilms are structured communities of bacteria that are more resistant to antibiotics and immune defenses, making them a significant challenge in treating infections. This finding suggests cardanol monoene could be a potential anti-biofilm agent but requires further research for clinical applications.